0001261380-16-000074.txt : 20160309
0001261380-16-000074.hdr.sgml : 20160309
20160309192518
ACCESSION NUMBER: 0001261380-16-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160308
FILED AS OF DATE: 20160309
DATE AS OF CHANGE: 20160309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRIDEX CORP
CENTRAL INDEX KEY: 0001006045
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 770210467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1230
BUSINESS ADDRESS:
STREET 1: 1212 TERRA BELLA AVE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 6509404700
MAIL ADDRESS:
STREET 1: 1212 TERRA BELLA AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Steckel Ronald
CENTRAL INDEX KEY: 0001304121
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27598
FILM NUMBER: 161495805
MAIL ADDRESS:
STREET 1: C/O FOXHOLLOW TECHNOLOGIES, INC.
STREET 2: 740 BAY ROAD
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-03-08
0001006045
IRIDEX CORP
IRIX
0001304121
Steckel Ronald
1212 TERRA BELLA AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
VP, Operations
Common Stock
2016-03-08
4
M
0
6250
3.99
A
75125
D
Common Stock
2016-03-08
4
S
0
6250
10.4481
D
68875
D
Common Stock
2016-03-08
4
M
0
3750
3.856
D
72625
D
Common Stock
2016-03-08
4
S
0
3750
10.4481
D
68875
D
Common Stock
2016-03-08
4
S
0
2000
10.4625
D
66875
D
Stock Option Right to Buy
3.99
2016-03-08
4
M
0
6250
0
D
2013-04-16
2019-04-16
Common Stock
6250
2083
D
Stock Option Right to Buy
3.856
2016-03-08
4
M
0
3750
0
D
2013-02-01
2017-01-01
Common Stock
3750
6250
D
The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $10.44 to $10.49 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.
The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.
/s/ Susan Bruce, Attorney-in-Fact for Ronald Steckel
2016-03-09